Charbel Fadel

Charbel Fadel

Auto-generated profile, based on publicly available information

Charbel Fadel

Department of Veterinary Sciences, University of Pisa, Viale delle Piagge, 2, 56124 Pisa, Italy; Department of Veterinary Medicine, Lebanese University, Faculty of Agronomy Bldg., University Street, Dekwaneh, Beirut, Lebanon

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2022 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Open access
CFCharbel Fadel
Charbel Fadel
BŁBEATA ŁEBKOWSKA-WIERUSZEWSKA
BEATA ŁEBKOWSKA-WIERUSZEWSKA
ISIrene Sartini
Irene Sartini
ALAndrzej Lisowski
Andrzej Lisowski
APAmnart Poapolathep
Amnart Poapolathep
MVMario Giorgi Dip Scienze Veterinarie
Mario Giorgi Dip Scienze Veterinarie
The aim of this study was to evaluate the pharmacokinetics (PK) of robenacoxib (RX), a COX‐2 selective non‐steroidal anti‐inflammatory drug, in sheep after single subcutaneous (SC), oral (PO), and intravenous (IV) administration. Five healthy female sheep underwent a three‐phase parallel study design with a washout period of 4 weeks, in which sheep received a 4 mg/kg SC dose in phase 1, a 4 mg/kg PO administration in phase 2, and a 2 mg/kg IV administration in phase 3. Plasma RX concentrations were measured over a 48 h period for each treatment using HPLC coupled to a UV multiple wavelength detector, and the PK parameters were estimated using a non‐compartmental method. Following IV administration, terminal elimination half‐life, volume of distribution at steady state, and total clearance were 2.64 h, 0.077 L/kg, and 0.056 L/h kg, respectively. The mean peak plasma concentrations following SC and PO administrations were 7.04 and 3.01 μg/mL, respectively. The mean bioavailability following SC and PO administrations were 45.98% and 16.58%, respectively. The SC route may be proposed for use in sheep. However, the multi‐dose and pharmacodynamic studies are necessary to establish more accurately its safety and efficacy in sheep.

28 May 2023 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Open access
CFCharbel Fadel
Charbel Fadel
BŁBEATA ŁEBKOWSKA-WIERUSZEWSKA
BEATA ŁEBKOWSKA-WIERUSZEWSKA
CZClaudia Zizzadoro
Claudia Zizzadoro
ALAndrzej Lisowski
Andrzej Lisowski
APAmnart Poapolathep
Amnart Poapolathep
MVMario Giorgi Dip Scienze Veterinarie
Mario Giorgi Dip Scienze Veterinarie
The purpose of this study was to assess the pharmacokinetics of robenacoxib (RX), a COX‐2 selective non‐steroidal anti‐inflammatory drug, in goats after single intravenous (IV), subcutaneous (SC) and oral (PO) administrations. 5‐month‐old healthy female goats (n = 8) were used. The animals were subjected to a three‐phase, two‐dose (2 mg/kg IV, 4 mg/kg SC, PO) unblinded, parallel study design, with a four‐month washout period between the IV and SC treatment, and a one‐week period between the SC and PO treatment. Blood was drawn from the jugular vein in heparinized vacutainer tubes at 0, 0.085 (for IV only), 0.25, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, 10 and 24 h. Plasma RX concentrations were measured using HPLC coupled to a UV multiple wavelength detector, and the data were pharmacokinetically analysed using ThothPro™ 4.3 software in a non‐compartmental approach. Following IV administration, terminal elimination half‐life, volume of distribution and total clearance were 0.32 h, 0.24 L/kg and 0.52 L/h/kg, respectively. For SC and PO, the mean peak plasma concentrations were 2.34 and 3.34 μg/mL at 1.50 and 0.50 h, respectively. The t1/2λz was significantly different between the IV and the extravascular (EV) administrations (0.32 h IV vs 1.37 h SC and 1.63 h PO), suggesting the occurrence of a flip‐flop phenomenon. The significant difference in Vd values between IV (0.24 L/kg) and EV (0.95 L/kg SC and 1.71 L/kg; corrected for F %) routes might have also triggered the t1/2λz difference. The absolute average SC and PO bioavailability were high (98% and 91%, respectively). In conclusion, the IV administration of RX might not be suitable for goats, due to its short t1/2λz. The EV routes, however, appear to be convenient for the drug's occasional use.

30 November 2023 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Open access
CFCharbel Fadel
Charbel Fadel
BŁBEATA ŁEBKOWSKA-WIERUSZEWSKA
BEATA ŁEBKOWSKA-WIERUSZEWSKA
KBKrzysztof Bourdo
Krzysztof Bourdo
APAmnart Poapolathep
Amnart Poapolathep
GHGeorges Hassoun
Georges Hassoun
MVMario Giorgi Dip Scienze Veterinarie
Mario Giorgi Dip Scienze Veterinarie
Metronidazole (MTZ) is a 5‐nitroimidazole anti‐bacterial and anti‐protozoal drug. In human and companion animal medicine, MTZ remains widely used due to its effectiveness against anaerobic bacteria and protozoa. In farm animals, however, MTZ is currently prohibited in several countries due to insufficient data on nitroimidazoles. The purpose of this study was to assess its pharmacokinetics (PK) in geese after single intravenous (IV) and oral (PO) administrations. Fifteen‐month old healthy male geese (n = 8) were used. Geese were subjected to a two‐phase, single‐dose (10 mg/kg IV, 50 mg/kg PO), open, longitudinal study design with a two‐week washout period between the IV and PO phases. Blood was drawn from the left wing vein to heparinized tubes at 0, 0.085 (for IV only), 0.25, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, 10, 24, and 48 h. Plasma MTZ concentrations were measured using HPLC coupled to an UV detector, and the data were pharmacokinetically analyzed using PKanalix™ software with a non‐compartmental approach. MTZ was still quantifiable and well above the LLOQ at 24 h after both routes of administration. Following IV administration, terminal elimination half‐life, volume of distribution, and total clearance were 5.47 h, 767 mL/kg, and 96 mL/h/kg, respectively. For the PO route, the bioavailability was high (85%), and the mean peak plasma concentration was 60.27 μg/mL at 1 h. When parameters were normalized for the dose, there were no statistically significant differences for any of the PK parameters between the two routes of administration. The study shows that oral administration of MTZ seems to be promising in geese, although comprehensive research on its pharmacodynamics and multiple‐dose studies are necessary before its adoption in geese can be further considered.

23 April 2024 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
CFCharbel Fadel
Charbel Fadel
AMAneliya Milanova
Aneliya Milanova
JSJelena Suran
Jelena Suran
ASAndrejs Sitovs
Andrejs Sitovs
TKTae-Won Kim
Tae-Won Kim
Cristina VercelliCristina Vercelli
Cristina Vercelli

7 June 2024 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
KBKrzysztof Bourdo
Krzysztof Bourdo
CFCharbel Fadel
Charbel Fadel
MVMario Giorgi Dip Scienze Veterinarie
Mario Giorgi Dip Scienze Veterinarie
ASAndrejs Sitovs
Andrejs Sitovs
APAmnart Poapolathep
Amnart Poapolathep
BŁBeata Łebkowska‐Wieruszewska
Beata Łebkowska‐Wieruszewska

13 June 2023 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Open access
CFCharbel Fadel
Charbel Fadel
BŁBEATA ŁEBKOWSKA-WIERUSZEWSKA
BEATA ŁEBKOWSKA-WIERUSZEWSKA
ALAndrzej Lisowski
Andrzej Lisowski
SLSeavchou Laut
Seavchou Laut
APAmnart Poapolathep
Amnart Poapolathep
MVMario Giorgi Dip Scienze Veterinarie
Mario Giorgi Dip Scienze Veterinarie
Robenacoxib (RX) is a veterinary cyclooxygenase‐2 selective inhibitor drug. It has never been tested on birds and is only labelled for use in cats and dogs. The purpose of this study was to assess its pharmacokinetics in geese after single intravenous (IV) and oral (PO) administrations. Four‐month healthy female geese (n = 8) were used. Geese were subjected to a two‐phase, single‐dose (2 mg/kg IV, 4 mg/kg PO), open, longitudinal study design with a four‐month washout period between the IV and the PO phases. Blood was collected from the left wing vein to heparinized tubes at 0, 0.085 (for IV only), 0.25, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, 10, and 24 h. Plasma RX concentrations were measured using HPLC coupled to an UV detector, and the data were pharmacokinetically analysed using ThothPro™ 4.3 software in a non‐compartmental approach. Following IV administration, terminal elimination half‐life, volume of distribution, and total clearance were 0.35 h, 0.34 L/kg, and 0.68 L/h/kg, respectively. For the PO route, the mean peak plasma concentration was 6.78 μg/mL at 0.50 h. The t1/2λz was very short and significantly different between the IV and PO administrations (0.35 h IV vs. 0.99 h PO), suggesting the occurrence of a flip‐flop phenomenon. The Cl values corrected for the F% were significantly different between IV and PO administrations. It might have been a consequence of the longitudinal study design and the altered physiological and environmental conditions after a 4‐month washout period. The absolute oral F% computed with the AUC method surpassed 150%, but after normalizing it to t1/2λz, it was 46%. In conclusion, the administration of RX might not be suitable for geese, due to its short t1/2λz.